Radiation Syndrome Treatment: Global Market Analysis 2019-2023 - The Increase in Nuclear Testing is a Key Driver for Market Growth

News provided by

Dec 10, 2018, 07:30 ET

DUBLIN, Dec. 10, 2018 /PRNewswire/ --

The "Global Radiation Syndrome Treatment Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The radiation syndrome treatment market will register a CAGR of more than 6% by 2023.

The latest trend gaining momentum in the market is the advent of regenerative therapy. According to the report, one of the major drivers for this market is the increase in nuclear testing. Further, the report states that one of the major factors hindering the growth of this market is the difficulty to diagnose radiation syndrome.

The advent of regenerative therapy is expected to help the market grow. The global radiation syndrome treatment market has seen strong advances in terms of treatment options. The advent of regenerative medicines such as stem-cell therapy is one among such advances. In stem-cell therapy, the stem cells are taken from the patient and are re-inserted to replace the damaged cells to treat or prevent a disease.

The increasing nuclear testing in South-East Asia in recent years has resulted in the rise in the symptoms of radiation toxicity and exposure in nearby countries. also, various scientists and pharmaceutical companies believe that the increasing testing of nuclear launches cause significant damage to the environment.

A major share of the global radiation syndrome treatment market is dominated by acute radiation syndrome, which is highly progressive by nature. Acute radiation effects the patients in less than 24 hours of exposure to radiation. The lack of diagnostic devices for radiation syndrome is major challenge faced by the market.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Amgen and Neumedicines the competitive environment is quite intense. Factors such as the increase in nuclear testing and the advent of regenerative therapy, will provide considerable growth opportunities to radiation syndrome treatment manufactures.

Key Players

Amgen
Neumedicines
Partner Therapeutics
Tonix Pharmaceuticals
Onconova Therapeutics

With the presence of a considerable number of companies, this market appears to be fragmented. The market is expected to witness the emergence of many international and regional radiation syndrome therapeutic companies who offer therapeutics for the treatment of HSC syndrome, CNS syndrome, GI syndrome, and cardiovascular syndrome caused by radiation poisoning.

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

Market ecosystem
Market characteristics
Market segmentation analysis

PART 04: MARKET SIZING

Market definition
Market sizing 2018
Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

PART 06: MARKET SEGMENTATION BY DISEASE

Market segmentation by disease
Comparison by disease
HSC syndrome - Market size and forecast 2018-2023
CNS syndrome - Market size and forecast 2018-2023
GI syndrome - Market size and forecast 2018-2023
Cardiovascular syndrome - Market size and forecast 2018-2023
Market opportunity by disease

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation
Geographic comparison
Americas - Market size and forecast 2018-2023
EMEA - Market size and forecast 2018-2023
APAC - Market size and forecast 2018-2023
Key leading countries
Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

Market drivers
Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

Overview
Landscape disruption
Competitive scenario

PART 13: VENDOR ANALYSIS

Vendors covered
Vendor classification
Market positioning of vendors
Amgen
Neumedicines
Onconova Therapeutics
Partner Therapeutics
Tonix Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/research/dff2rf/radiation?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets